The large BVF Partners sale is the dominant signal; monitor for any forthcoming pipeline updates or earnings pre-announcements that may have prompted the reduction. Given the size, this could precede a negative catalyst or reflect a strategic shift by a key holder. Watch for additional insider filings in the coming weeks.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 29 $109.32entry
- T+1 · 5mo ago +4.89%α +4.12% · $114.67
- T+5 · 4mo ago +4.98%α +3.59% · $114.76
- T+20 · 4mo ago +1.14%α +1.42% · $110.57
- T+60 · 8w ago +11.65%α +7.27% · $122.06
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A significant insider selling cluster at Kymera Therapeutics, led by director BVF Partners' $89.2M open-market sale, totaling $90.6M in sales over a week. This represents ~0.94% of market cap, a material reduction by a major shareholder. The selling is concentrated among directors, with only a small C-suite sale, suggesting potential portfolio rebalancing or a cautious view on near-term catalysts.
Key Financial Metrics
Key Facts
- BVF Partners (director) sold 837,914 shares for $89.2M on 2026-06-26.
- Director Bruce Booth sold ~185,330 shares totaling ~$19.3M across multiple trades.
- Chief Business Officer Noah Goodman sold 2,500 shares for $272,500 (small relative to total).
- Total open-market sales of $90.6M represent ~0.94% of Kymera's $9.6B market cap.
- 10 unique insiders filed Form 4s in the cluster window, but only 3 engaged in open-market selling.
Financial Impact
Insider selling of $90.6M, or 0.94% of market cap, concentrated in director-level sales.
Risk Factors
- Further insider selling could pressure the stock.
- Potential negative clinical or regulatory news may be anticipated by insiders.
- High institutional ownership (93% analyst bullish) may buffer but does not guarantee price stability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KYMR-1782514125315 |
Track record
37 reports on KYMR
7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +60.99% at T+60 after the Jun 8, 2026 report. 9 of 13 went positive at some point.
Filters
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $127.09 Now $125.85 −0.98% settles Dec 2
- Oct 29, 202618d ago 8-K Neutral 5/10 No price data
- Oct 29, 202618d ago Press Release Bearish 5/10 Entry $122.60 Now $125.85 −2.65% settles Nov 27
- Oct 28, 202619d ago Press Release Neutral 5/10 Entry $122.60 Now $125.85 +2.65% settles Nov 27
- Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $110.85 Now $125.85 +13.53% settles Nov 20
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $105.48 to $118.63 Now $125.85 +19.31% ▲ +12.47% +13.07% vs SPY
- Jul 7, 202618w ago Insider Cluster Bearish 5/10 Entry $114.16 to $105.48 Now $125.85 −10.24% ▲ +7.60% +10.88% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 5/10 Entry $114.76 to $100.31 Now $125.85 −9.66% ▲ +12.59% +13.44% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers